Evogene (EVGN) Inventory (2021 - 2025)

Evogene (EVGN) has disclosed Inventory for 5 consecutive years, with $210000.0 as the latest value for Q4 2025.

  • Quarterly Inventory fell 88.46% to $210000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $210000.0 through Dec 2025, down 88.46% year-over-year, with the annual reading at $210000.0 for FY2025, 88.46% down from the prior year.
  • Inventory hit $210000.0 in Q4 2025 for Evogene, down from $1.8 million in the prior quarter.
  • In the past five years, Inventory ranged from a high of $1.8 million in Q4 2024 to a low of $76000.0 in Q4 2023.
  • Historically, Inventory has averaged $552600.0 across 5 years, with a median of $210000.0 in 2025.
  • Biggest five-year swings in Inventory: surged 2293.42% in 2024 and later crashed 88.46% in 2025.
  • Year by year, Inventory stood at $92000.0 in 2021, then skyrocketed by 515.22% to $566000.0 in 2022, then plummeted by 86.57% to $76000.0 in 2023, then soared by 2293.42% to $1.8 million in 2024, then plummeted by 88.46% to $210000.0 in 2025.
  • Business Quant data shows Inventory for EVGN at $210000.0 in Q4 2025, $1.8 million in Q4 2024, and $76000.0 in Q4 2023.